BioAtla Enters Into Strategic License And Option Agreement With Pfizer For A New Class Of Antibody Therapeutics

SAN DIEGO, December 7, 2015 – PRNewswire – BioAtla LLC, a biotechnology company focused on the development of Conditionally Active Biologic (CAB) antibody therapeutics and a strategic partn
December 07, 2015

BioDuro, LLC Adds Industry Veteran CFO to Executive Team

SAN DIEGO, November 18, 2015 – PRNewswire – BioDuro, LLC, a global CRO leader focused on preclinical chemistry, biology, and fully outsourced integrated drug development services for pharma
November 18, 2015

BioDuro, LLC Announces Merger with Formex, LLC, and New Leadership

BioDuro, LLC merges with Formex, LLC, a leader in pharmaceutical API formulation and manufacturing in San Diego, CA, bringing new leadership and capabilities.
November 11, 2015

Integrating Drug Discovery and Development to Improve Efficiency and Candidate Success

Industry research shows that an estimated 94% of drugs that pass animal and non-animal preclinical tests will fail in human tests,¹ and only 11.8% of products that enter clinical development rece
October 21, 2015

Formex Acquires Gerteis MINI-PACTOR™ and Korsch XL 100™

SAN DIEGO, August 3, 2015 – PRNewswire – Formex, LLC (“Formex”), a contract drug development and manufacturing organization (CDMO), has introduced the Gerteis MINI-PACTOR™ and the Korsch XL 100™ to Fo
August 03, 2015
Total 84 12...91011121314151617
We use necessary cookies to ensure our website functions properly and to keep it secure. These necessary cookies must be enabled. By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You can personalize or withdraw your consent at any moment by clicking on the link "Cookies Settings". For more information on how we use cookies, including the total lifespan of cookies and the identity of third parties intervening on our website, please consult the Privacy Notice available in the site footer.
Accept all